These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8126405)

  • 41. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.
    Walensky RP; Wood R; Fofana MO; Martinson NA; Losina E; April MD; Bassett IV; Morris BL; Freedberg KA; Paltiel AD;
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):26-35. PubMed ID: 21068674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV.
    Zarkin GA; Lindrooth RC; Demiralp B; Wechsberg W
    Health Serv Res; 2001 Jun; 36(2):335-55. PubMed ID: 11409816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The college student, the dentist, and the North Carolina senator: risk analysis and risk management of HIV transmission from health care worker to patient.
    Robinson EN; de Bliek R
    Med Decis Making; 1996; 16(1):86-91. PubMed ID: 8717603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV screening programs in US emergency departments: a cross-site comparison of structure, process, and outcomes.
    Torres GW; Heffelfinger JD; Pollack HA; Barrera SG; Rothman RE
    Ann Emerg Med; 2011 Jul; 58(1 Suppl 1):S104-13. PubMed ID: 21684388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution in testing technology enables some urban EDs to implement HIV screening at relatively low cost.
    ED Manag; 2011 Oct; 23(10):109-12. PubMed ID: 21972754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of voluntary HIV screening in Russia.
    Tole SP; Sanders GD; Bayoumi AM; Galvin CM; Vinichenko TN; Brandeau ML; Owens DK
    Int J STD AIDS; 2009 Jan; 20(1):46-51. PubMed ID: 19103893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the population-level prevention effect of emergency department-based HIV testing in the United States: a research framework and commentary.
    Holtgrave DR
    Ann Emerg Med; 2011 Jul; 58(1 Suppl 1):S164-7. PubMed ID: 21684397
    [No Abstract]   [Full Text] [Related]  

  • 48. Emergency department management of occupational exposures: cost analysis of rapid HIV test.
    Kallenborn JC; Price TG; Carrico R; Davidson AB
    Infect Control Hosp Epidemiol; 2001 May; 22(5):289-93. PubMed ID: 11428439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative HIV testing: is it less expensive than universal precautions?
    Lawrence VA; Gafni A; Kroenke K
    J Clin Epidemiol; 1993 Nov; 46(11):1219-27. PubMed ID: 8229097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cost-benefit analysis of screening strategies by human immunodeficiency virus in French blood donors].
    Djossou F; Salmi LR; Lawson-Ayayi S; Huët C; Perez P; Mathoulin-Pélissier S; Salamon R
    Transfus Clin Biol; 1999 Jun; 6(3):180-8. PubMed ID: 10422211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cost-effectiveness of human immunodeficiency virus screening in pregnancy.
    Ecker JL
    Am J Obstet Gynecol; 1996 Feb; 174(2):716-21. PubMed ID: 8623812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Universal voluntary testing and treatment for prevention of HIV transmission.
    Dieffenbach CW; Fauci AS
    JAMA; 2009 Jun; 301(22):2380-2. PubMed ID: 19509386
    [No Abstract]   [Full Text] [Related]  

  • 53. Screening for HIV: ratios, risks and rationality.
    Jones ME
    Anaesth Intensive Care; 1996 Apr; 24(2):191-6. PubMed ID: 9133194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-Effectiveness of Voluntary HIV Testing Strategies in a Very Low-Prevalence Country, the Republic of Korea.
    Lee YH; Bang JH; Park SM; Kang CR; Cho SI; Oh MD; Lee JK
    J Korean Med Sci; 2018 Nov; 33(46):e304. PubMed ID: 30416412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Cost-Effectiveness of Integrating HIV Counseling and Testing into Primary Health Care in the Ukraine.
    Johns B; Doroshenko O; Tarantino L; Cowley P
    AIDS Behav; 2017 Mar; 21(3):655-664. PubMed ID: 27654316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis.
    Martin EG; Paltiel AD; Walensky RP; Schackman BR
    Value Health; 2010 Dec; 13(8):893-902. PubMed ID: 20950323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic evaluation, human immunodeficiency virus infection and screening: a review and critical appraisal of economic studies.
    Dibosa-Osadolor O; Roberts T
    Int J Technol Assess Health Care; 2010 Jul; 26(3):301-8. PubMed ID: 20584359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cost-effectiveness of HIV testing: accounting for differential participation rates.
    Paltiel AD; Kaplan EH
    Med Decis Making; 1997; 17(4):490-5. PubMed ID: 9343808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Think HIV: why physicians should lower their threshold for HIV testing.
    Freedberg KA; Samet JH
    Arch Intern Med; 1999 Sep; 159(17):1994-2000. PubMed ID: 10510984
    [No Abstract]   [Full Text] [Related]  

  • 60. Cost-effectiveness of HIV screening of pregnant women in hospitals of the Paris area. The Paris-Tours study group of antenatal transmission of HIV, Group '9 maternites'.
    Le Gales C; Moatti JP
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):25-33. PubMed ID: 2115850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.